Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Drugs - Real World Outcomes|September 13, 2024
Residual Depressive Symptoms in Treatment-Resistant Bipolar Depression Following Short-Term Ketamine AdministrationMichał Pastuszak, Wiesław Jerzy Cubała, Aleksander Kwaśny
Asian Journal of Psychiatry|July 17, 2024
Treatment-emergent symptoms during short-term ketamine administration in treatment-resistant bipolar depression: A retrospective cross-sectional descriptive studyMichał Pastuszak, Wiesław Jerzy Cubała, Aleksander Kwaśny
Therapeutic Advances in Psychopharmacology|November 20, 2025
Ketamine dosing formula in treatment-resistant bipolar depressionAleksander Kwaśny, Wiesław Jerzy Cubała, Alina Wilkowska
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 8, 2025
Safety and tolerability of NN-dimethyltryptamine (DMT) in healthy volunteers and Major Depressive Disorder (MDD) patients: A systematic review of early-phase clinical trialsDamian Swieczkowski, Aleksander Kwaśny, Wiesław Jerzy Cubała
Therapeutic Advances in Psychopharmacology|July 2, 2026
Readability of informed consent forms from ClinicalTrials.gov in ketamine clinical trials for mental health conditions: a cross-sectional analysisDamian Swieczkowski, Aleksander Kwaśny, Wiesław Jerzy Cubała
Frontiers in Psychiatry|October 4, 2024
Short-term safety and tolerability profile of 5-methoxy-N,N-dimethyltryptamine in human subjects: a systematic review of clinical trialsAleksander Kwaśny, Alina Wilkowska, Wiesław Jerzy Cubała
Frontiers in Psychiatry|March 5, 2024
Anhedonia and depression severity measures during ketamine administration in treatment-resistant depressionAleksander Kwaśny, Wiesław Jerzy Cubała, Adam Włodarczyk
Psychiatry Research|December 16, 2025
Cross-sectional analysis of ongoing clinical trials involving lamotrigine for mental disorders: Insights from ClinicalTrials.gov and the EU clinical trialsDamian Swieczkowski, Aleksander Kwaśny, Wiesław Jerzy Cubała
Pharmaceuticals (Basel, Switzerland)|April 28, 2023
Effect of Ketamine on Sleep in Treatment-Resistant Depression: A Systematic ReviewAleksander Kwaśny, Adam Włodarczyk, Damian Ogonowski, et al.
Pharmacological Reports : PR|August 29, 2024
Sleep alterations in treatment-resistant depression patients undergoing ketamine treatmentAleksander Kwaśny, Wiesław Jerzy Cubała, Adam Włodarczyk, et al.
Pageof 4